320 related articles for article (PubMed ID: 33816284)
1. Pretreatment Inflammatory-Nutritional Biomarkers Predict Responses to Neoadjuvant Chemoradiotherapy and Survival in Locally Advanced Rectal Cancer.
Wang Y; Chen L; Zhang B; Song W; Zhou G; Xie L; Yu D
Front Oncol; 2021; 11():639909. PubMed ID: 33816284
[TBL] [Abstract][Full Text] [Related]
2. Prognostic value of mesorectal package area in patients with locally advanced rectal cancer following neoadjuvant chemoradiotherapy: A retrospective cohort study.
Guan B; Huang X; Xia H; Guan G; Xu B
Front Oncol; 2022; 12():941786. PubMed ID: 36263216
[TBL] [Abstract][Full Text] [Related]
3. Neutrophil-to-Lymphocyte Ratio and Platelet-to-Lymphocyte Ratio as Prognostic Factors in Locally Advanced Rectal Cancer.
Duque-Santana V; López-Campos F; Martin-Martin M; Valero M; Zafra-Martín J; Couñago F; Sancho S
Oncology; 2023; 101(6):349-357. PubMed ID: 36273439
[TBL] [Abstract][Full Text] [Related]
4. Prognostic Role of Peripheral Neutrophil-Lymphocyte Ratio (NLR) and Platelet-Lymphocyte Ratio (PLR) in Patients with Rectal Cancer Undergoing Neoadjuvant Chemoradiotherapy.
Ergen ŞA; Barlas C; Yıldırım C; Öksüz DÇ
J Gastrointest Cancer; 2022 Mar; 53(1):151-160. PubMed ID: 33392960
[TBL] [Abstract][Full Text] [Related]
5. Pretreatment blood biomarkers combined with magnetic resonance imaging predict responses to neoadjuvant chemoradiotherapy in locally advanced rectal cancer.
Shi X; Zhao M; Shi B; Chen G; Yao H; Chen J; Wan D; Gu W; He S
Front Oncol; 2022; 12():916840. PubMed ID: 36016621
[TBL] [Abstract][Full Text] [Related]
6. Preoperative Fibrinogen-Albumin Ratio Index (FARI) is a Reliable Prognosis and Chemoradiotherapy Sensitivity Predictor in Locally Advanced Rectal Cancer Patients Undergoing Radical Surgery Following Neoadjuvant Chemoradiotherapy.
Lu S; Liu Z; Zhou X; Wang B; Li F; Ma Y; Wang W; Ma J; Wang Y; Wang H; Fu W
Cancer Manag Res; 2020; 12():8555-8568. PubMed ID: 32982448
[TBL] [Abstract][Full Text] [Related]
7. Prognostic value of preoperative prognostic nutritional index and its associations with systemic inflammatory response markers in patients with stage III colon cancer.
Peng J; Zhang R; Zhao Y; Wu X; Chen G; Wan D; Lu Z; Pan Z
Chin J Cancer; 2017 Dec; 36(1):96. PubMed ID: 29268783
[TBL] [Abstract][Full Text] [Related]
8. Neutrophil-to-lymphocyte and platelet-to-lymphocyte ratios as predictive and prognostic markers in patients with locally advanced rectal cancer treated with neoadjuvant chemoradiation.
Dudani S; Marginean H; Tang PA; Monzon JG; Raissouni S; Asmis TR; Goodwin RA; Gotfrit J; Cheung WY; Vickers MM
BMC Cancer; 2019 Jul; 19(1):664. PubMed ID: 31277604
[TBL] [Abstract][Full Text] [Related]
9. Prognostic value of pretreatment systemic inflammatory markers in patients with locally advanced rectal cancer following neoadjuvant chemoradiotherapy.
Zhang Y; Liu X; Xu M; Chen K; Li S; Guan G
Sci Rep; 2020 May; 10(1):8017. PubMed ID: 32415197
[TBL] [Abstract][Full Text] [Related]
10. An inflammation index-based prediction of treatment response to neoadjuvant chemoradiotherapy for rectal mucinous adenocarcinoma.
Sun Y; Huang Z; Chi P
Int J Clin Oncol; 2020 Jul; 25(7):1299-1307. PubMed ID: 32274615
[TBL] [Abstract][Full Text] [Related]
11. Evaluation of Neutrophil-Lymphocyte Ratio and Platelet-Lymphocyte Ratio on Predicting Responsiveness to Neoadjuvant Chemoradiotherapy in Locally Advanced Rectal Cancer Patients.
Liu M; Feng Y; Zhang Y; Liu H
Biomed Res Int; 2022; 2022():3839670. PubMed ID: 36212713
[TBL] [Abstract][Full Text] [Related]
12. Value of Pretreatment Inflammation-nutrition Score to Predict Non-response to Neoadjuvant Chemotherapy in Locally Advanced Rectal Cancer.
Zhang GC; Xu YY; Wu YC; Cheng N; Lian R; Wang X
Biomed Environ Sci; 2023 Oct; 36(10):940-948. PubMed ID: 37932062
[TBL] [Abstract][Full Text] [Related]
13. Significance of neutrophil-to-lymphocyte ratio, platelet-to-lymphocyte ratio, lymphocyte-to-monocyte ratio and prognostic nutritional index for predicting clinical outcomes in T1-2 rectal cancer.
Xia LJ; Li W; Zhai JC; Yan CW; Chen JB; Yang H
BMC Cancer; 2020 Mar; 20(1):208. PubMed ID: 32164623
[TBL] [Abstract][Full Text] [Related]
14. Predictive Value of the Neutrophil-Lymphocyte Ratio for Tumor Regression Grade and Prognosis of Local Advanced Rectal Cancer Patients Undergoing Neoadjuvant Chemoradiotherapy.
Li S; Wang D; Wei R; Yu G; Wang X; Jiang Z
Technol Cancer Res Treat; 2023; 22():15330338231202611. PubMed ID: 37807729
[TBL] [Abstract][Full Text] [Related]
15. Systemic Immune-inflammation Index (SII) Predicts Pathological Complete Response to Neoadjuvant Chemoradiotherapy in Locally Advanced Rectal Cancer.
Eraslan E; Adas YG; Yildiz F; Gulesen AI; Karacin C; Arslan UY
J Coll Physicians Surg Pak; 2021 Apr; 31(4):399-404. PubMed ID: 33866724
[TBL] [Abstract][Full Text] [Related]
16. Utility of prognostic nutritional index and systemic immune-inflammation index in oral cancer treatment.
Kubota K; Ito R; Narita N; Tanaka Y; Furudate K; Akiyama N; Chih CH; Komatsu S; Kobayashi W
BMC Cancer; 2022 Apr; 22(1):368. PubMed ID: 35392843
[TBL] [Abstract][Full Text] [Related]
17. Perineural and lymphovascular invasion predicts for poor prognosis in locally advanced rectal cancer after neoadjuvant chemoradiotherapy and surgery.
Sun Q; Liu T; Liu P; Luo J; Zhang N; Lu K; Ju H; Zhu Y; Wu W; Zhang L; Fan Y; Liu Y; Li D; Zhu Y; Liu L
J Cancer; 2019; 10(10):2243-2249. PubMed ID: 31258728
[No Abstract] [Full Text] [Related]
18. The combination of pre-neoadjuvant chemoradiotherapy inflammation biomarkers could be a prognostic marker for rectal cancer patients.
Zhang J; Zhang L; Gou Y; Diao P; Hu Y
Sci Rep; 2022 Mar; 12(1):4286. PubMed ID: 35277532
[TBL] [Abstract][Full Text] [Related]
19. Lymphocyte-monocyte ratio as a predictive marker for pathological complete response to neoadjuvant therapy in esophageal squamous cell carcinoma.
Zhao K; Wang C; Shi F; Li M; Yu J
Transl Cancer Res; 2020 Jun; 9(6):3842-3853. PubMed ID: 35117751
[TBL] [Abstract][Full Text] [Related]
20. Diagnostic value of preoperative inflammatory markers in patients with glioma: a multicenter cohort study.
Zheng SH; Huang JL; Chen M; Wang BL; Ou QS; Huang SY
J Neurosurg; 2018 Sep; 129(3):583-592. PubMed ID: 29099300
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]